Type I interferon system activation and association with disease manifestations in systemic sclerosis

Gunnar Alm

doi:10.1136/ard.2009.121400

Type I interferon system activation and association with disease manifestations in systemic sclerosis

Gunnar Alm

Publikation: Bidrag till tidskrift › Artikel i vetenskaplig tidskrift › Peer review

Sammanfattning

Conclusion An activated type I IFN system previously seen in several other systemic autoimmune diseases is also present in SSc and may contribute to the vascular pathology and affect the profibrotic process.

Originalspråk	Engelska
Sidor (från-till)	1396-1402
Antal sidor	7
Tidskrift	Annals of the Rheumatic Diseases
Volym	69
Nummer	7
DOI	https://doi.org/10.1136/ard.2009.121400
Status	Publicerad - 2010

Åtkomst av dokument

10.1136/ard.2009.121400

Andra filer och länkar

Permanent länk till denna sida

Citera det här

@article{5d5c260bdd13476aa403079093bf9f30,

title = "Type I interferon system activation and association with disease manifestations in systemic sclerosis",

abstract = "Conclusion An activated type I IFN system previously seen in several other systemic autoimmune diseases is also present in SSc and may contribute to the vascular pathology and affect the profibrotic process.",

author = "Gunnar Alm",

year = "2010",

doi = "10.1136/ard.2009.121400",

language = "English",

volume = "69",

pages = "1396--1402",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - Type I interferon system activation and association with disease manifestations in systemic sclerosis

AU - Alm, Gunnar

PY - 2010

Y1 - 2010

N2 - Conclusion An activated type I IFN system previously seen in several other systemic autoimmune diseases is also present in SSc and may contribute to the vascular pathology and affect the profibrotic process.

AB - Conclusion An activated type I IFN system previously seen in several other systemic autoimmune diseases is also present in SSc and may contribute to the vascular pathology and affect the profibrotic process.

UR - https://res.slu.se/id/publ/48064

U2 - 10.1136/ard.2009.121400

DO - 10.1136/ard.2009.121400

M3 - Journal article

C2 - 20472592

SN - 0003-4967

VL - 69

SP - 1396

EP - 1402

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 7

ER -